Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

IF 13.4 1区医学 Q1 HEMATOLOGY

Leukemia Pub Date : 2025-09-03 DOI:10.1038/s41375-025-02747-8

Tim R. Mocking, Lukas H. Haaksma, Tom Reuvekamp, Angèle Kelder, Willemijn J. Scholten, Lok Lam Ngai, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Jacqueline Cloos, Costa Bachas

引用次数: 0

Abstract Image

查看原文本刊更多论文

计算可测量的急性髓系白血病残留疾病评估：HOVON-SAKK-132试验的回顾性验证

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia 医学-血液学

CiteScore

18.10

自引率

3.50%

发文量

270

审稿时长

3-6 weeks

期刊介绍： Title: Leukemia Journal Overview: Publishes high-quality, peer-reviewed research Covers all aspects of research and treatment of leukemia and allied diseases Includes studies of normal hemopoiesis due to comparative relevance Topics of Interest: Oncogenes Growth factors Stem cells Leukemia genomics Cell cycle Signal transduction Molecular targets for therapy And more Content Types: Original research articles Reviews Letters Correspondence Comments elaborating on significant advances and covering topical issues